Regístrese
Buscar en
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
Toda la web
Inicio Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
ISSN: 2253-8089

The Revista Española de Medicina Nuclear e Imagen Molecular (Spanish Journal of Nuclear Medicine and Molecular Imaging), was founded in 1982, and is the official journal of the Spanish Society of Nuclear Medicine and Molecular Imaging, which has more than 700 members.
The Journal, which publishes 6 regular issues per year, has the promotion of research and continuing education in all fields of Nuclear Medicine as its main aim. For this, its principal sections are Originals, Clinical Notes, Images of Interest, and Special Collaboration articles. The works may be submitted in Spanish or English and are subjected to a peer review process.
In 2009, it became the leading Spanish journal in the field of Medical Imaging on having an Impact Factor , awarded by the Journal Citation Reports.

See more

Indexed in:

Science Citation Index Expander, Medline, IME, Bibliomed, EMBASE/Excerpta Medica, Healthstar, Cancerlit, Toxine, Inside Conferences, Scopus

See more

Follow us:

0.928 (2018)
1.202 (2017)
0.951 (2016)
0.983 (2015)
1.054 (2014)
0.938 (2013)
0.863 (2012)
0.894 (2011)
Impact Factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two receding years.

© Clarivate Analytics, Journal Citation Reports 2017 2018

Impact Factor 2018
0.928
CiteScore 2018

CiteScore measures average citations received per document published. Read more

CiteScore 2018
0.54

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR
0.235

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP
0.288
See more
Hide
Issue
Vol. 38. Issue 6.
Pages 341-408 (November - December 2019)
Editorial
Radioguided surgery of non palpable lesions: we have much to sow
Goñi Gironés Elena, Paredes Barranco Pilar
Rev Esp Med Nucl Imagen Mol. 2019;38:341-2
Original article
125I radioactive seed localization for non-palpable lesions in breast cancer
R. Sánchez Sánchez, A.D. González Jiménez, A.C. Rebollo Aguirre, I. Mendoza Arnau, S. Menjón Beltrán, M.E. Vergara Alcaide, J.L. Osorio Ceballos, J.M. Llamas Elvira
Rev Esp Med Nucl Imagen Mol. 2019;38:343-7
Is there any improvement in clinical staging with 18F-FDG PET/CT compared to surgical staging in cases of lung cancer?
Gonca Kara Gedik, Farise Yilmaz
Rev Esp Med Nucl Imagen Mol. 2019;38:348-54
Relationships between hypoxia induced factor-1α and 18F-FDG PET/CT parameters in colorectal cancer
Zekiye Hasbek, Hatice Ozer, Seyit Ahmet Erturk, Eda Erdiş, Birsen Yucel, Esra Çiftçi, Ali Çakmakcilar
Rev Esp Med Nucl Imagen Mol. 2019;38:355-61
Segmentation of gliomas in 18F-Fluorocholine PET/CT. A multiapproach study
Ana María García Vicente, Julián Pérez-Beteta, Germán Andrés Jiménez Londoño, Mariano Amo-Salas, Francisco José Pena Pardo, Maikal Villena Martín, José María Borrás Moreno, Ángel Soriano Castrejón
Rev Esp Med Nucl Imagen Mol. 2019;38:362-9
Special collaboration
Radioembolization in liver tumors
L. Carrion-Martin, J. Orcajo Rincón, A. Rotger, M. Gonzalez-Leyte, L. Márquez Pérez, M. Echenagusia, A. Matilla
Rev Esp Med Nucl Imagen Mol. 2019;38:370-81
Clinical notes
PET/CT imaging with somatostatin analogues for the assessment of neuroendocrine tumours, initial experience
M. Suárez-Piñera, L. Visa, L. Ilzarbe, A. Zugazaga, I. Poves, A. Mestre-Fusco, M. Iglesias
Rev Esp Med Nucl Imagen Mol. 2019;38:382-5
Interesting images
Hybrid imaging (SPECT/CT) in the evaluation and management of a patient with heterotopic calcification and hip prostheses
Y. Herrera-Martínez, P. Fernández-Rodríguez, J.J. Martín-Marcuartu, J.M. Jiménez-Hoyuela, R. García Jiménez
Rev Esp Med Nucl Imagen Mol. 2019;38:386-8
Benign differentiation of treated neuroblastoma as a cause of false positive by 123I-MIBG SPECT/CT. Usefulness of 18F-FDG PET/CT
J.R. Garcia, P. Bassa, M. Soler, A. Jaramillo, S. Ortiz, E. Riera
Rev Esp Med Nucl Imagen Mol. 2019;38:389-90
Desmoid fibroma in the clavicle detected by 18F-NaF PET/CT
Zi Wang, Yuxiao Xia, Yanhong Zhao, Huipan Liu, Yue Chen
Rev Esp Med Nucl Imagen Mol. 2019;38:391-2
Maxillary myofibroblastic tumor. Initial staging and treatment response evaluation with 18F-FDG PET/CT
I. Acevedo Báñez, R. Fernández López, I. Borrego Dorado, L. Caballero Gullón, Á. de-Bonilla Damiá, J.M. Jiménez Hoyuela
Rev Esp Med Nucl Imagen Mol. 2019;38:393-4
18F-FDG PET/CT for extramedullary relapse of acute leukemia of ambiguous lineage
Álvaro De Bonilla Damiá, Rosa Fernández López, Irene Acevedo Báñez, Cristina Calderón Cabrera, Agueda Molinos Quintana, Isabel Borrego Dorado
Rev Esp Med Nucl Imagen Mol. 2019;38:395-6
Continuing education
Role of Nuclear Medicine in the diagnosis of musculoskeletal infection: a review
E. Noriega-Álvarez, L. Domínguez Gadea, M.P. Orduña Diez, V. Peiró Valgañón, S. Sanz Viedma, R. García Jiménez
Rev Esp Med Nucl Imagen Mol. 2019;38:397-407
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

es en pt
Política de cookies Cookies policy Política de cookies
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.